1-4 of 4
Yifan Pang
Close
Sort by
Journal Articles

Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis

Clinical Trials & Observations
Parth Sharma, Annapurna Saksena, Adolfo Diaz, Yifan Pang, Parth Desai
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2534–2537.
https://doi.org/10.1182/bloodadvances.2022008968
Published: 2023
Journal Articles

A starting point for the phenotypic classification of pulmonary chronic graft-versus-host disease

Yifan Pang, Ananth V. Charya, Michael B. Keller, Arlene Sirajuddin, Yi-Ping Fu, Noa G. Holtzman, Steven Z. Pavletic, Sean Agbor-Enoh
Journal: Blood Advances
Blood Adv (2022) 6 (17): 4987–4988.
https://doi.org/10.1182/bloodadvances.2022008394
Published: 2022
Journal Articles

The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease

Yifan Pang, Ananth V. Charya, Michael B. Keller, Arlene Sirajuddin, Yi-Ping Fu, Noa G. Holtzman, Steven Z. Pavletic, Sean Agbor-Enoh
Journal: Blood Advances
Blood Adv (2022) 6 (14): 4196–4207.
https://doi.org/10.1182/bloodadvances.2021006885
Published: 2022
Includes: Supplemental data
Journal Articles

Post–hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics

Yazan Migdady, Yifan Pang, Shelley S. Kalsi, Richard Childs, Sally Arai
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2707–2721.
https://doi.org/10.1182/bloodadvances.2021006279
Published: 2022